Navi: COMPASS

COMPASS

E-mail Print PDF

A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major CV events in Patients with Coronary or Peripheral Artery Disease (COMPASS- CV OutcoMes for People using Anticoagulation StrategieS)

Status : Ongoing

Sponsor/Support : Bayer & Population Health Research Institute (PHRI)

Duration : 2013 - 2018

Principle Investigator : Prof. Dato' Dr. Khalid Yusoff

Co-Investigator/s : Dr. Rizmy Najme Khir, Dr. Lim Chiao Wen

Study Manager : Sazreza Shahadan

Study Member : Saleha Baharuddin

Venue : Selayang Campus

TOOLS for the researcher

  • Clinical research/trial development
  • Statisticians to consult on study design and analysis
  • Facilitate proposal¬† submission process
  • Study coordinators
  • Subject recruitment registry
  • Collaboration with Clinical Research Organizations (CRO)s Read more...

FACILITIES for the researcher

  • Consultation rooms
  • Day care centre
  • Patient monitoring
  • Satellite pharmacy
  • On site radiological imaging and specialised tests in various subspecialties eg cardiology, respiratory¬†medicine, gastroenterology
  • Archiving and storage Read more...

TRAINING @ CenTRE

The CenTRE conducts various teaching and training programmes to educate and train researchers in translational research and epidemiology, enabling them to conduct high quality research. This can be in the form of seminars, lectures, workshops or short courses. Read more...

Visitors Counter

Number of visitors since 2010
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday313
mod_vvisit_counterThis week2088
mod_vvisit_counterThis month8989

Today: Jun 23, 2017

Take a survey

How did you hear about Us ?







Results

Staff News

Note Headline.


CenTRE Staff Birtday:
NOV 2016
- FADHLINA AB MAJID
- RASYIDAH SALLEH
- MOHAMMAD NAFIQ ARSHAD